Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Vagal Nerve Stimulation for Post COVID Fatigue

NCT: NCT05445427 · COMPLETED

NCT IDNCT05445427
StatusCOMPLETED
Start Date2022-12-21
Completion2024-03-28

Brief Summary

The purpose of this study is to evaluate the impact of vagal nerve stimulation on patients with post COVID syndrome who have fatigue and headache.

Frequently Asked Questions

What is Vagal Nerve Stimulation for Post COVID Fatigue?

Vagal Nerve Stimulation for Post COVID Fatigue is a clinical trial registered under NCT05445427. Current status: COMPLETED.

What is the status of NCT05445427?

The current status of NCT05445427 (Vagal Nerve Stimulation for Post COVID Fatigue) is: COMPLETED.

When did Vagal Nerve Stimulation for Post COVID Fatigue start?

Vagal Nerve Stimulation for Post COVID Fatigue started on 2022-12-21.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.